Advanced Search:

HQL - TeklaLife Sciences Investors

$12.99  0.19 (1.48%)

Updated: 01:17 Apr 23, 2024 EST

Next Hour's AI Forecast

N/A

Avg. Accuracy (AI)

N/A

Next Session's AI Forecast

N/A

Avg. Accuracy (AI)

N/A

Next Week's AI Forecast

N/A

Trend's Accuracy (AI)

N/A

TeklaLife Sciences Investors's Position Within the Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

TEKLALIFE SCIENCES INVESTORS - HISTORICAL DATA 6M

  • Last price

    $ 12.99

  • Daily change

    $ 0.19

  • Previous Close

    $ 12.8

  • Last Updated

    01:17 Apr 23, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0 -0.31 -0.14 0.1 -0.03

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0 0.72 0.77 0.85 0.82

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
N/A N/A 48.78% 15.15%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
0 -100% 12.99 -1.74% 13.22 0.53% 13.15

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.91 42.86 0.8 47.64

TeklaLife Sciences Investors Technical Analysis News

TeklaLife Sciences Investors

100 Federal Street
19th Floor
Boston, MA 02110
United States
617 772 8500
https://www.teklacap.com/hql.html

Description

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Corporate Governance

Tekla Life Sciences Investors’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

TEKLALIFE SCIENCES INVESTORS'S HOLDERS RANK

List of holders with stock participation in TeklaLife Sciences Investors.